Bayesian Capital Management, LP

Position in NVO — Novo Nordisk A S

CIK 1632551 Brooklyn, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$407,490

-$643,560 QoQ

Shares Held

8,500

-70.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#782

of 1,348 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bayesian Capital Management, LP holds $5,153,335 across 7 Drug Manufacturers - General names. NVO ranks #5 (7.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	9,100	$1,149,694
2	BMY	Bristol Myers Squibb Co	19,200	$1,106,304
3	GSK	GSK plc	18,100	$948,802
4	AMGN	Amgen Inc	2,384	$863,294
5	NVO	Novo Nordisk A S This page	8,500	$407,490
6	NVS	Novartis AG	2,365	$370,642
7	SNY	Sanofi	7,199	$307,109

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$407,490	8,500	-70.3%	Shares	Sole	2026-08-14
2026-03-31	$1,051,050	28,600	-58.1%	Shares	Sole	2026-05-15
2025-09-30	$3,789,967	68,300	+889.9%	Shares	Sole	2025-11-14
2025-06-30	$476,238	6,900	-44.4%	Shares	Sole	2025-08-14
2025-03-31	$861,056	12,400	-50.2%	Shares	Sole	2025-05-15
2024-12-31	$2,141,898	24,900	+586.0%	Shares	Sole	2025-02-14
2023-12-31	$375,523	3,630	-81.2%	Shares	Sole	2024-02-14
2022-12-31	$2,619,911	19,358	+178.2%	Shares	Sole	2023-02-14
2022-09-30	$693,225	6,958	+152.3%	Shares	Sole	2022-11-14
2022-06-30	$307,323	2,758	+25.4%	Shares	Sole	2022-08-15
2022-03-31	$244,310	2,200	-35.8%	Shares	Sole	2022-05-16
2021-09-30	$329,026	3,427	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.